Project Grant R34AA031589
Award Date
9/25/24
Completion Date
8/31/27
Dollars Obligated
$244K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Awardee
Brown University (E3FDXZ6TBHW3)
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
Providence, RI 02912, USA
Similar Awards
This Project Grant award for $545,282 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, aims to investigate neural mechanisms associated with cognitive reappraisal and alcohol cue reactivity in individuals with alcohol use disorder (AUD) during early abstinence. The key objectives are to: 1) determine how neural mechanisms related to reappraisal and alcohol cue-reactivity change across early abstinence...
This $999,393 Cooperative Agreement awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) is funding investigational new drug (IND)-enabling studies for a novel therapeutic candidate aimed at the chronic management of pathological hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis for the treatment of alcohol use disorder (AUD). The project will manufacture and validate the test article, develop and validate...
This $856,625 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), supports an exploratory randomized controlled trial (RCT) of the effects of oral semaglutide on alcohol craving and consumption. The University of Colorado-Denver, as the prime awardee, will conduct this 2-year study to assess the safety, tolerability, and efficacy of semaglutide, a glucagon-like peptide-1 (GLP-1) agonist, compared to placebo...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, is funding a Phase II clinical trial to evaluate the use of the drug tirzepatide (Zepbound) in adults with co-occurring alcohol use disorder and overweight/obesity. The $211,247 award supports an 8-week double-blind study at the University of Southern California to assess the effects of tirzepatide on alcohol use, weight,...
This $1,373,036 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will support a research project to enhance understanding and prediction of heavy drinking episodes during initial recovery from alcohol use disorder (AUD). The project aims to leverage wearable biosensors and artificial intelligence to develop real-time predictive models that can forecast high-risk drinking periods and identify the...
This federal Project Grant award, totaling $165,279.00, was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award aims to understand the neural markers of incentive salience for alcohol cues and the role of context in brain-behavior relationships for alcohol use disorder (AUD). The research will leverage a combined laboratory-ambulatory study design to characterize the brain-behavior...
This Project Grant award in the amount of $404,508.00 was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award aims to examine interleukin-1β (IL-1β) synaptic regulation and its role in cognitive impairment during early withdrawal and protracted abstinence from chronic alcohol exposure in male and female mice. The overarching goal is to determine the neuroimmune mechanisms by which chronic...
This $481,428 Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) Alcohol Research Programs (CFDA 93.273) will support the "Translating Research into Practice on Alcohol and Polysubstance Use Disorders by Educating the Interprofessional Primary Care Team" project. The key products and services to be delivered under this 4-year project include: Two 16-session cohorts of Project ECHO (Extension for Community Healthcare Outcomes) Alcohol Use Disorder...
This Project Grant award of $594,784 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund a postmortem, multi-omic study of brains from 341 total subjects to identify novel lasting transcriptomic and epigenetic changes in biological pathways that may serve as biomarkers and therapeutic targets for alcohol use disorder (AUD). The research will analyze RNA sequencing and whole-genome bisulfite sequencing data across 8 brain...
This $223,531 Project Grant awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) will fund a Phase Ia/b proof-of-concept study to evaluate the use of the FDA-approved drug diclofenac as a potential novel treatment for alcohol use disorder (AUD). The study will be conducted by the University of Maryland, Baltimore and aims to determine the optimal dosage of diclofenac that increases levels of the neuroprotective metabolite...